GLP-1s drive a historic shift in traditional drug spending increases, outpacing specialty drug trends for the first time.

It is a rough era for national pharmacy chains like Walgreens, CVS, and Rite-Aid, closing hundreds of stores due to changing ...

The public is being invited to provide feedback with the asset manager planning to submit an application to the city council ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.